Arbutus Biopharma (ABUS) Stock Research

Over a week ago

Arbutus Biopharma expects to return $230M in capital to shareholders

ABUS

Jul 16, 7:46 AM

Arbutus Biopharma receives $178M settlement agreement from Moderna

Jul 16, 7:44 AM

Arbutus initiates patent infringement actions against Pfizer, BioNTech

Jul 16, 7:43 AM

Arbutus Biopharma granted Fast Track designation for imdusiran

ABUS

Apr 15, 7:33 AM

Arbutus Biopharma price target lowered by $1.50 at Jefferies, here's why

Apr 7, 8:31 AM

Roivant Sciences price target raised by $4 at Jefferies, here's why

Apr 7, 8:31 AM

What You Missed On Wall Street On Wednesday

+28

Mar 4, 4:19 PM

Midday Fly By: Stocks climb as oil prices pull back

+25

Mar 4, 11:52 AM

Unusually active option classes on open March 4th

Mar 4, 9:40 AM

Video: Moderna advances as settlement seen removing share overhang

Mar 4, 8:55 AM

Morning Movers: Moderna rises after entering COVID settlement agreement

+13

Mar 4, 8:53 AM

Moderna resolves litigation with Arbutus, to pay up to $2.25B in settlement

Mar 4, 6:46 AM

Roivant Sciences price target raised by $3 at BofA, here's why

Mar 4, 6:42 AM

Genevant, Arbutus announce $2.25B global settlement with Moderna

Mar 3, 4:22 PM

Arbutus faces higher bar to argue infringement by Moderna, says Jefferies

Feb 2, 2:45 PM

Moderna reverses lower after court issues memo in patent fight with Arbutus

Feb 2, 2:29 PM

Moderna rises after Delaware court issues memo in patent fight with Arbutus

Feb 2, 1:50 PM

European Patent Office ruling 'clear win' for Moderna, says Citi

Jan 19, 12:25 PM

Arbutus says European patent revoked by European Patent Office

Jan 19, 11:34 AM

What You Missed On Wall Street On Friday

+29

Jan 16, 4:29 PM

Midday Fly By: PNC reports Q4 beat, Regions reports quarterly miss

+28

Jan 16, 11:58 AM

Arbutus Biopharma loses patent appeal in Europe, Bloomberg reports

Jan 16, 10:36 AM

Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)

ABUS

Nov 13, 7:37 AM

Arbutus Biopharma to present imdusiran, AB-101 data at The Liver Meeting 2025

ABUS

Oct 7, 8:21 AM

No more stories

Over a week ago

Arbutus Biopharma expects to return $230M in capital to shareholders

ABUS

Jul 16, 7:46 AM

Arbutus Biopharma receives $178M settlement agreement from Moderna

Jul 16, 7:44 AM

Arbutus initiates patent infringement actions against Pfizer, BioNTech

Jul 16, 7:43 AM

Arbutus Biopharma granted Fast Track designation for imdusiran

ABUS

Apr 15, 7:33 AM

Arbutus Biopharma price target lowered by $1.50 at Jefferies, here's why

Apr 7, 8:31 AM

Roivant Sciences price target raised by $4 at Jefferies, here's why

Apr 7, 8:31 AM

What You Missed On Wall Street On Wednesday

+28

Mar 4, 4:19 PM

Midday Fly By: Stocks climb as oil prices pull back

+25

Mar 4, 11:52 AM

Unusually active option classes on open March 4th

Mar 4, 9:40 AM

Video: Moderna advances as settlement seen removing share overhang

Mar 4, 8:55 AM

Morning Movers: Moderna rises after entering COVID settlement agreement

+13

Mar 4, 8:53 AM

Moderna resolves litigation with Arbutus, to pay up to $2.25B in settlement

Mar 4, 6:46 AM

Roivant Sciences price target raised by $3 at BofA, here's why

Mar 4, 6:42 AM

Genevant, Arbutus announce $2.25B global settlement with Moderna

Mar 3, 4:22 PM

Arbutus faces higher bar to argue infringement by Moderna, says Jefferies

Feb 2, 2:45 PM

Moderna reverses lower after court issues memo in patent fight with Arbutus

Feb 2, 2:29 PM

Moderna rises after Delaware court issues memo in patent fight with Arbutus

Feb 2, 1:50 PM

European Patent Office ruling 'clear win' for Moderna, says Citi

Jan 19, 12:25 PM

Arbutus says European patent revoked by European Patent Office

Jan 19, 11:34 AM

What You Missed On Wall Street On Friday

+29

Jan 16, 4:29 PM

Midday Fly By: PNC reports Q4 beat, Regions reports quarterly miss

+28

Jan 16, 11:58 AM

Arbutus Biopharma loses patent appeal in Europe, Bloomberg reports

Jan 16, 10:36 AM

Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)

ABUS

Nov 13, 7:37 AM

Arbutus Biopharma to present imdusiran, AB-101 data at The Liver Meeting 2025

ABUS

Oct 7, 8:21 AM

No more stories

Company News

Charts